BE884760A - BREAKABLE TABLET FOR CONTROLLED AND DELAYED RELEASE OF THE ACTIVE SUBSTANCE - Google Patents

BREAKABLE TABLET FOR CONTROLLED AND DELAYED RELEASE OF THE ACTIVE SUBSTANCE

Info

Publication number
BE884760A
BE884760A BE0/201740A BE201740A BE884760A BE 884760 A BE884760 A BE 884760A BE 0/201740 A BE0/201740 A BE 0/201740A BE 201740 A BE201740 A BE 201740A BE 884760 A BE884760 A BE 884760A
Authority
BE
Belgium
Prior art keywords
controlled
active substance
delayed release
breakable tablet
breakable
Prior art date
Application number
BE0/201740A
Other languages
French (fr)
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of BE884760A publication Critical patent/BE884760A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
BE0/201740A 1979-08-16 1980-08-13 BREAKABLE TABLET FOR CONTROLLED AND DELAYED RELEASE OF THE ACTIVE SUBSTANCE BE884760A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH7514/79A CH648754A5 (en) 1979-08-16 1979-08-16 Pharmaceutical slow release tablet

Publications (1)

Publication Number Publication Date
BE884760A true BE884760A (en) 1981-02-13

Family

ID=4326338

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/201740A BE884760A (en) 1979-08-16 1980-08-13 BREAKABLE TABLET FOR CONTROLLED AND DELAYED RELEASE OF THE ACTIVE SUBSTANCE

Country Status (4)

Country Link
JP (1) JPS5659708A (en)
BE (1) BE884760A (en)
CH (1) CH648754A5 (en)
ZA (1) ZA805015B (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT207980Z2 (en) * 1986-02-24 1988-03-14 Smithkline Beckman Corp PHARMACEUTICAL PAD WITH DISCOIDAL BODY WITH OPPOSITE ROUNDED FACES.
TW407502U (en) * 1991-09-10 2000-10-01 Takeda Chemical Industries Ltd Divisible tablet
UA67802C2 (en) * 1998-10-23 2004-07-15 Пфайзер Рісьоч Енд Дівелепмент Компані, Н.В./С.А. CONTROLLED-RELEASE FORMULATIONS FOR ORAL ADMINISTRATION CONTAINING cGMP PDE-5 INHIBITOR (VARIANTS), METHOD FOR ITS PREPARATION AND METHOD FOR TREATING ERECTILE DYSFUNCTION
GB0030340D0 (en) * 2000-12-13 2001-01-24 Sorex Ltd Briquettes
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE10361596A1 (en) 2003-12-24 2005-09-29 Grünenthal GmbH Process for producing an anti-abuse dosage form
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10336400A1 (en) 2003-08-06 2005-03-24 Grünenthal GmbH Anti-abuse dosage form
DE102005005446A1 (en) 2005-02-04 2006-08-10 Grünenthal GmbH Break-resistant dosage forms with sustained release
CA2566310C (en) * 2004-05-21 2014-05-13 Lawrence Solomon Scored pharmaceutical tablets comprising a plurality of segments
DE102004032049A1 (en) 2004-07-01 2006-01-19 Grünenthal GmbH Anti-abuse, oral dosage form
DE102005005449A1 (en) 2005-02-04 2006-08-10 Grünenthal GmbH Process for producing an anti-abuse dosage form
BRPI0520797B8 (en) * 2005-11-18 2021-05-25 Accu Break Tech Inc bilayer compressed pharmaceutical dosage form
WO2007149860A1 (en) * 2006-06-19 2007-12-27 Accu-Break Technologies, Inc. Segmented pharmaceutical dosage forms
TWI454288B (en) 2008-01-25 2014-10-01 Gruenenthal Chemie Pharmaceutical dosage form
FR2928836B1 (en) * 2008-03-21 2011-08-26 Servier Lab SECURE GALENIC FORM FOR MODIFIED RELEASE OF THE ACTIVE INGREDIENT
PT2273983T (en) 2008-05-09 2016-10-28 Gruenenthal Gmbh Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
ES2560210T3 (en) 2009-07-22 2016-02-17 Grünenthal GmbH Tamper-resistant dosage form for oxidation-sensitive opiates
CN102573805A (en) 2009-07-22 2012-07-11 格吕伦塔尔有限公司 Hot-melt extruded controlled release dosage form
TWI516286B (en) 2010-09-02 2016-01-11 歌林達股份有限公司 Tamper resistant dosage form comprising an anionic polymer
RU2604676C2 (en) 2010-09-02 2016-12-10 Грюненталь Гмбх Destruction-resistant dosage form containing an inorganic salt
CN103857386A (en) 2011-07-29 2014-06-11 格吕伦塔尔有限公司 Tamper-resistant tablet providing immediate drug release
LT2736495T (en) 2011-07-29 2017-11-10 Grünenthal GmbH Tamper-resistant tablet providing immediate drug release
JP6117249B2 (en) 2012-02-28 2017-04-19 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング Tamper resistant dosage forms comprising a pharmacologically active compound and an anionic polymer
CA2868142A1 (en) 2012-04-18 2013-10-24 Grunenthal Gmbh Tamper resistant and dose-dumping resistant pharmaceutical dosage form
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
TW201402155A (en) * 2012-06-12 2014-01-16 Daiichi Sankyo Co Ltd Tablet having ingestion easiness and dividability
US9737490B2 (en) 2013-05-29 2017-08-22 Grünenthal GmbH Tamper resistant dosage form with bimodal release profile
JP6445537B2 (en) 2013-05-29 2018-12-26 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング Tamper-resistant dosage forms containing one or more particles
CN105682643B (en) 2013-07-12 2019-12-13 格吕伦塔尔有限公司 Tamper resistant dosage form containing ethylene-vinyl acetate polymer
AU2014356581C1 (en) 2013-11-26 2020-05-28 Grunenthal Gmbh Preparation of a powdery pharmaceutical composition by means of cryo-milling
WO2015087561A1 (en) * 2013-12-09 2015-06-18 第一三共株式会社 Readily dividable tablet
JP5719479B1 (en) * 2013-12-09 2015-05-20 第一三共株式会社 Tablet with easy splitting
EP3142646A1 (en) 2014-05-12 2017-03-22 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
US9872835B2 (en) 2014-05-26 2018-01-23 Grünenthal GmbH Multiparticles safeguarded against ethanolic dose-dumping
CN107889459A (en) 2015-04-24 2018-04-06 格吕伦塔尔有限公司 Tamper resistant dosage form with release immediately and to solvent-extracted resistance
EP3346991A1 (en) 2015-09-10 2018-07-18 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations

Also Published As

Publication number Publication date
CH648754A5 (en) 1985-04-15
JPS6361928B2 (en) 1988-11-30
JPS5659708A (en) 1981-05-23
ZA805015B (en) 1981-08-26

Similar Documents

Publication Publication Date Title
BE884760A (en) BREAKABLE TABLET FOR CONTROLLED AND DELAYED RELEASE OF THE ACTIVE SUBSTANCE
PT71706B (en) Divisible tablet having controlled and delayed release of the active substance
NL7803309A (en) PHARMACEUTICAL PREPARATION OF THE MULTI-UNIT TYPE WITH CONTROLLED RELEASE OF THE ACTIVE SUBSTANCE.
MX5502E (en) PROCEDURE FOR THE PREPARATION OF ETERS AND ESTERS OF OXIMES
MX8352A (en) PROCEDURE FOR THE ELABORATION OF SULPHONYLLENE AND RESULTING PRODUCT.
NL300007I1 (en) Preparation for the controlled release of an active substance.
NO790865L (en) DERIVATIVES OF IODOPROPARGYL AND PROCEDURES FOR THE PREPARATION OF THE SAME
ES497517A0 (en) PROCEDURE FOR THE PREPARATION OF NEW IMINOACIDS AND THEIR DERIVATIVES.
BR8201133A (en) DEVICE FOR CONTROLLED RELEASE OF ONE OR MORE ACTIVE MATERIALS
ES489628A0 (en) PROCEDURE FOR THE OBTAINING OF DERIVATIVES OF TETRAHIDRO- PIRIDINA AND PIPERIDINA
NL7800014A (en) MEDICINAL FOR IMPROVEMENT OF BLOODING AND WOUND HEALING.
AR217465A1 (en) PA ARCOSMETIC PENCIL AND PROCEDURE FOR THE ELABORATION OF SUCH PENCIL
ES493995A0 (en) PROCEDURE FOR THE PREPARATION OF OXIMIC ETERS AND OXIMIC ESTERS OF DIPHENILIC ETERS
IT1093048B (en) PROCEDURE FOR THE PRODUCTION OF ODORLESS AND PROLATE UREA FERTILIZERS DIZIANDIAMMIDE
AR221355A1 (en) PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF PIRROLIDINIL AND PIRROLIDINILMETIL-BENZAMIDAS
NO800601L (en) PROCEDURE FOR THE PREPARATION OF WATER PASTS OF PARTICULATE MATERIAL
SE7707999L (en) SILICATE POLYMERATED MATERIAL AND PROCEDURE FOR THE MANUFACTURE OF THE SAME
NL7805742A (en) FLASH LIGHT SYSTEM FOR PROVIDING HIGHLY AUDIBLE AND VISIBLE SIGNALS.
NO800664L (en) ANALOGY PROCEDURE FOR THE PREPARATION OF HYDROXYPYRIMIDINE DERIVATIVES
ES492616A0 (en) PROCEDURE FOR THE PREPARATION OF NEW ESTERS OF SUGAR AND GLYCOXIDES
BE857122A (en) NEW PHARMACEUTICAL COMPOSITION ALLOWING A CONTROLLED RELEASE OF THE ACTIVE SUBSTANCE
NL7802835A (en) FORMING PREPARATION AND PROCEDURE FOR FORMING PRODUCTS THEREOF.
NL7809652A (en) METHOD AND DESIGN FOR THE CONTINUOUS TURNING OF STRONG-SHAPED MATERIAL OF LARGER CROSS-SECTION.
NO811628L (en) PROCEDURE FOR THE PREPARATION OF CARBAPENAM AND CARBAPEN-2-EM DERIVATIVES.
BE886759A (en) PHARMACEUTICAL PREPARATIONS OF THERAPEUTIC VALUE FOR THE TREATMENT OF ACUTE LONIES SOME SHOCK CONDITIONS AND HYPERFIBRINOLYSIS

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: NOVARTIS A.G.

Effective date: 20000813